BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 32424097)

  • 21. MicroRNA-9 promotes proliferation of leukemia cells in adult CD34-positive acute myeloid leukemia with normal karyotype by downregulation of Hes1.
    Tian C; You MJ; Yu Y; Zhu L; Zheng G; Zhang Y
    Tumour Biol; 2016 Jun; 37(6):7461-71. PubMed ID: 26678889
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased expression of miR-24 is associated with acute myeloid leukemia with t(8;21).
    Yin JY; Tang Q; Qian W; Qian J; Lin J; Wen XM; Zhou JD; Zhang YY; Zhu XW; Deng ZQ
    Int J Clin Exp Pathol; 2014; 7(11):8032-8. PubMed ID: 25550847
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Knockout of both miR-15/16 loci induces acute myeloid leukemia.
    Lovat F; Fassan M; Sacchi D; Ranganathan P; Palamarchuk A; Bill M; Karunasiri M; Gasparini P; Nigita G; Distefano R; Veneziano D; Dorrance AM; Garzon R; Croce CM
    Proc Natl Acad Sci U S A; 2018 Dec; 115(51):13069-13074. PubMed ID: 30478046
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MiR-181 family: regulators of myeloid differentiation and acute myeloid leukemia as well as potential therapeutic targets.
    Su R; Lin HS; Zhang XH; Yin XL; Ning HM; Liu B; Zhai PF; Gong JN; Shen C; Song L; Chen J; Wang F; Zhao HL; Ma YN; Yu J; Zhang JW
    Oncogene; 2015 Jun; 34(25):3226-39. PubMed ID: 25174404
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endogenous Tumor Suppressor microRNA-193b: Therapeutic and Prognostic Value in Acute Myeloid Leukemia.
    Bhayadia R; Krowiorz K; Haetscher N; Jammal R; Emmrich S; Obulkasim A; Fiedler J; Schwarzer A; Rouhi A; Heuser M; Wingert S; Bothur S; Döhner K; Mätzig T; Ng M; Reinhardt D; Döhner H; Zwaan CM; van den Heuvel Eibrink M; Heckl D; Fornerod M; Thum T; Humphries RK; Rieger MA; Kuchenbauer F; Klusmann JH
    J Clin Oncol; 2018 Apr; 36(10):1007-1016. PubMed ID: 29432078
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Knockdown of miR-128a induces Lin28a expression and reverts myeloid differentiation blockage in acute myeloid leukemia.
    De Luca L; Trino S; Laurenzana I; Tagliaferri D; Falco G; Grieco V; Bianchino G; Nozza F; Campia V; D'Alessio F; La Rocca F; Caivano A; Villani O; Cilloni D; Musto P; Del Vecchio L
    Cell Death Dis; 2017 Jun; 8(6):e2849. PubMed ID: 28569789
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of let-7a-2-3p or/and miR-188-5p as prognostic biomarkers in cytogenetically normal acute myeloid leukemia.
    Jinlong S; Lin F; Yonghui L; Li Y; Weidong W
    PLoS One; 2015; 10(2):e0118099. PubMed ID: 25646775
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A minicircuitry of microRNA-9-1 and RUNX1-RUNX1T1 contributes to leukemogenesis in t(8;21) acute myeloid leukemia.
    Fu L; Shi J; Liu A; Zhou L; Jiang M; Fu H; Xu K; Li D; Deng A; Zhang Q; Pang Y; Guo Y; Hu K; Zhou J; Wang Y; Huang W; Jing Y; Dou L; Wang L; Xu K; Ke X; Nervi C; Li Y; Yu L
    Int J Cancer; 2017 Feb; 140(3):653-661. PubMed ID: 27770540
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dysregulation of miR-200s clusters as potential prognostic biomarkers in acute myeloid leukemia.
    Zhou JD; Zhang LC; Zhang TJ; Gu Y; Wu DH; Zhang W; Ma JC; Wen XM; Guo H; Lin J; Qian J
    J Transl Med; 2018 May; 16(1):135. PubMed ID: 29784043
    [TBL] [Abstract][Full Text] [Related]  

  • 30. miR-15a-5p and miR-21-5p contribute to chemoresistance in cytogenetically normal acute myeloid leukaemia by targeting PDCD4, ARL2 and BTG2.
    Vandewalle V; Essaghir A; Bollaert E; Lenglez S; Graux C; Schoemans H; Saussoy P; Michaux L; Valk PJM; Demoulin JB; Havelange V
    J Cell Mol Med; 2021 Jan; 25(1):575-585. PubMed ID: 33270982
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epigenetic priming with decitabine followed by low dose idarubicin and cytarabine in acute myeloid leukemia evolving from myelodysplastic syndromes and higher-risk myelodysplastic syndromes: a prospective multicenter single-arm trial.
    Zhou X; Mei C; Zhang J; Lu Y; Lan J; Lin S; Zhang Y; Kuang Y; Ren Y; Ma L; Wei J; Ye L; Xu W; Li K; Lu C; Jin J; Tong H
    Hematol Oncol; 2020 Oct; 38(4):531-540. PubMed ID: 32469434
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular pathways mediating MDS/AML with focus on AML1/RUNX1 point mutations.
    Harada Y; Harada H
    J Cell Physiol; 2009 Jul; 220(1):16-20. PubMed ID: 19334039
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MicroRNA-106b~25 cluster is upregulated in relapsed MLL-rearranged pediatric acute myeloid leukemia.
    Verboon LJ; Obulkasim A; de Rooij JD; Katsman-Kuipers JE; Sonneveld E; Baruchel A; Trka J; Reinhardt D; Pieters R; Cloos J; Kaspers GJ; Klusmann JH; Zwaan CM; Fornerod M; van den Heuvel-Eibrink MM
    Oncotarget; 2016 Jul; 7(30):48412-48422. PubMed ID: 27351222
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Functional implications of microRNAs in acute myeloid leukemia by integrating microRNA and messenger RNA expression profiling.
    Havelange V; Stauffer N; Heaphy CC; Volinia S; Andreeff M; Marcucci G; Croce CM; Garzon R
    Cancer; 2011 Oct; 117(20):4696-706. PubMed ID: 21455993
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Apoptosis, bcl-2 expression and p53 accumulation in myelodysplastic syndrome, myelodysplastic-syndrome-derived acute myelogenous leukemia and de novo acute myelogenous leukemia.
    Kurotaki H; Tsushima Y; Nagai K; Yagihashi S
    Acta Haematol; 2000; 102(3):115-23. PubMed ID: 10692673
    [TBL] [Abstract][Full Text] [Related]  

  • 36. miR-378 inhibits cell growth and enhances apoptosis in human myelodysplastic syndromes.
    Kuang X; Wei C; Zhang T; Yang Z; Chi J; Wang L
    Int J Oncol; 2016 Nov; 49(5):1921-1930. PubMed ID: 27633496
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Promoter methylation of DAPK1, E-cadherin and thrombospondin-1 in de novo and therapy-related myeloid neoplasms.
    Greco M; D'Alò F; Scardocci A; Criscuolo M; Fabiani E; Guidi F; Di Ruscio A; Migliara G; Pagano L; Fianchi L; Chiusolo P; Hohaus S; Leone G; Voso MT
    Blood Cells Mol Dis; 2010 Oct; 45(3):181-5. PubMed ID: 20655775
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cytogenetic and genetic pathways in therapy-related acute myeloid leukemia.
    Qian Z; Joslin JM; Tennant TR; Reshmi SC; Young DJ; Stoddart A; Larson RA; Le Beau MM
    Chem Biol Interact; 2010 Mar; 184(1-2):50-7. PubMed ID: 19958752
    [TBL] [Abstract][Full Text] [Related]  

  • 39. miR-15b/16-2 deletion promotes B-cell malignancies.
    Lovat F; Fassan M; Gasparini P; Rizzotto L; Cascione L; Pizzi M; Vicentini C; Balatti V; Palmieri D; Costinean S; Croce CM
    Proc Natl Acad Sci U S A; 2015 Sep; 112(37):11636-41. PubMed ID: 26324892
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acquired copy number alterations of miRNA genes in acute myeloid leukemia are uncommon.
    Ramsingh G; Jacoby MA; Shao J; De Jesus Pizzaro RE; Shen D; Trissal M; Getz AH; Ley TJ; Walter MJ; Link DC
    Blood; 2013 Oct; 122(15):e44-51. PubMed ID: 24009227
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.